🟢 Johnson & Johnson is trading 3.17% up — no clear catalyst identified

Johnson & Johnson is trading 3.17% up at €232.80, with no clearly reported company-specific catalyst identified for the October 7 move.

• A pre-market report noted an earlier 0.29% gain; the cited psoriasis-study announcement was dated October 2, not a new October 7 catalyst.
• The S&P 500 and Dow are sharply lower, which does not explain the gain. No volume data was supplied, so trading activity cannot be assessed.